I just watched the video and the doctor states she has treated two children with the clinical trial therapy, derived from bone marrow stem cells. Both were successful recoveries. In a prior newscast from the same news station in August there is specific reference made to remestemcel-L being used in the trial, so I think it is safe to assume this is the same Mesoblast trial with at least one additional new success case. The story also indicates that US CDC has now counted over 1200 cases of MIS-C across the country.
- Forums
- ASX - By Stock
- Ann: EAP for Remestemcel-L in Children with MIS-C due to COVID-19
I just watched the video and the doctor states she has treated...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.11 |
Change
0.010(0.91%) |
Mkt cap ! $1.261B |
Open | High | Low | Value | Volume |
$1.09 | $1.11 | $1.07 | $4.794M | 4.399M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 14500 | $1.10 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.11 | 141676 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 14500 | 1.100 |
2 | 93112 | 1.095 |
2 | 37684 | 1.090 |
3 | 40400 | 1.085 |
2 | 61100 | 1.080 |
Price($) | Vol. | No. |
---|---|---|
1.110 | 141676 | 5 |
1.115 | 41050 | 3 |
1.120 | 157964 | 9 |
1.125 | 61233 | 3 |
1.130 | 111595 | 5 |
Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |